Bacterial DNA as an evolutionary conserved ligand signalling danger of infection to immune cells

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 17, Issue 7, 1998, Pages 464-469

  Heeg, K ^a   Sparwasser, T ^a   Lipford, G B ^a   Hacker H ^a   Zimmermann, S ^a   Wagner, H ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; CARBOHYDRATE; CD14 ANTIGEN; CYTOKINE; CYTOSINE; DINUCLEOTIDE; ENDOTOXIN; GALACTOSAMINE; GUANINE; IMMUNOMODULATING AGENT; LIGAND; LIPOTEICHOIC ACID; OLIGONUCLEOTIDE; PEPTIDOGLYCAN; RECEPTOR;

ALLERGY; ANTIGEN PRESENTING CELL; BACTERIAL CELL WALL; BACTERIAL INFECTION; DENDRITIC CELL; EUKARYOTIC CELL; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HELPER CELL; HOST PARASITE INTERACTION; HUMAN; IMMUNE SYSTEM; IMMUNOSTIMULATION; INFLAMMATORY CELL; MACROPHAGE; METHYLATION; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; SEPTIC SHOCK;

EID: 0031724538     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01691128     Document Type: Review

References (54)

1. Medzitov R, Janeway CA: Innate immunity: the virtues of a nonclonal system of recognition. Cell (1997), 91:295-298
2. Marrack P, Kappler J: The antigen-specific, major histocompatibility complex-restricted receptor on T cells. Advances in Immunology (1986), 38:1-30
3. Pugin J, Heumann D, Tomasz A, Kravchenko VV, Akamatsu Y, Nishijima M, Glauser MP, Tobias PS, Ulevitch RJ: CD14 is a pattern recognition receptor. Immunity Cell Press (1994), 1:509-516
4. Rietschel ET, Brade H: Bacterial endotoxins. Scientific American (1992), 267:54-61
5. de Smedt T, Pajak B, Muraille E, Lespagnard L, Heinen E, de Baetselier P, Urbain J, Leo O, Moser M: Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. Journal of Experimental Medicine (1996), 184:1413-1424
6. Bendelac A, Fearon DT: Innate immunity: innate pathways that control acquired immunity. Current Opinion in Immunology (1997), 9:1-3
7. Medzhitov R, Janeway CA: Innate immunity: impact on the adaptive immune response. Current Opinion in Immunology (1997), 9:4-9
8. Fearon DT, Locksley RM: The instructive role of innate immunity in the acquired immune response. Science (1996), 272:50-54
9. Tracey KJ, Beutler B, Lowry SF, Merryweather J, Wolpe S, Milsark IW, Hariri RJ, Fahey TJ, Zentella A, Albert JD, Shires GT, Cerami A: Shock and tissue injury induced by recombinant human cachetin. Science (1986), 234:470-474
10. Glauser MP, Zanetti G, Baumgartner JD, Cohen J: Septic shock: pathogenesis. Lancet (1991), 338:732-736
11. Hack CE, Aarden LA, Thijs LG: Role of cytokines in sepsis. Advances in Immunology (1997), 66:101-195
12. Miethke T, Wahl C, Heeg K, Echtenacher B, Krammer PH, Wagner H: T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. Journal of Experimental Medicine (1992), 175:91-98
13. Bhakdi S, Walev I, Jonas D, Palmer M, Weller U, Suttorp N, Grimminger F, Seeger W: Pathogenesis of sepsis syndrome: possible relevance of pore-forming bacterial toxins. Current Topics in Microbiology and Immunology (1996), 216:101-118
14. Weidemann B, Brade H, Rietschel ET, Dziarski R, Bazil V, Kusumoto S, Flad HD, Ulmer AJ: Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures. Infection and Immunity (1994), 62:4709-4715
15. Cleveland MG, Gorham JD, Murphy TL, Tuomanen E, Murphy KM: Lipoteichoic acid preparations of gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway. Infection and Immunity (1996), 64:1906-1912
16. Heumann D, Barras C, Severin A, Glauser MP, Tomasz A: Gram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin 6 by human monocytes. Infection and Immunity (1994), 62:2715-2721
17. Blank C, Luz C, Bendigs S, Wagner H, Heeg K: Superantigen and endotoxin synergize in the induction of lethal shock. European Journal of Immunology (1997), 27:825-833
18. Tarkowski A, Wagner H: Arthritis and sepsis caused by Staphylococcus aureus: can the tissue injury be reduced by modulating the host's immune system? Molecular Medicine Today (1998), 4:15-18
19. Pisetsky DS: Immune activation by bacterial DNA: a new genetic code. Immunity Cell Press (1996), 5:303-310
20. Hergersberg M: Biological aspects of cytosine methylation in eukaryotic cells. Experientia (1991), 47:1171-1185
21. Tokunaga T, Yano O, Kuramoto E, Kimura Y, Yamamoto T, Kataoka T, Yamamoto S: Synthetic oligonucleotides with particular base sequences from the cDNA encoding proteins of Mycobacterium bovis BCG induce interferons and activate natural killer cells. Microbiology and Immunology (1992), 36:55-66
22. Yamamoto S, Yamamoto T, Kataoka T, Kuramoto E, Yano O, Tokunaga T: Unique palindromic sequences in synthetic oligonucleotides A required to induce IFN and augment IFN-mediated natural killer activity. Journal of Immunology (1992), 148:4072-4076
23. Messina JP, Gilkeson GS, Pisetsky DS: Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA. Journal of Immunology (1991), 147:1759-1764
24. Yamamoto T, Yamamoto S, Kataoka T, Tokunaga T: Ability of oligonucleotides with certain palindromes to induce interferon production and augment natural killer cell activity is associated with their base length. Antisense Research and Development (1994), 4:119-122
25. Pisetsky DS, Reich C: Stimulation of in vitro proliferation of murine lymphocytes by synthetic oligonucleotides. Molecular Biology Reports (1993), 18:217-221
26. Krieg AM, Yi AK, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, Koretzky GA, Klinman DM: CpG motifs in bacterial DNA trigger direct B-cell activation. Nature (1995), 374:546-549
27. Liang H, Nishioka Y, Reich CF, Pisetsky DS, Lipsky PE: Activation of human B cells by phosphorothioate oligonucleotides. Journal of Clinical Investigations (1996), 98:1119-1129
28. Klinman DM, Yi AK, Beaucage SL, Conover J, Krieg AM: CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proceedings of the National Academy of Science USA (1996), 93:2879-2883
29. Yi AK, Klinman DM, Martin TL, Matson S, Krieg AM: Rapid immune activation by CpG motifs in bacterial DNA. Systemic induction of IL-6 transcription through an antioxidant-sensitive pathway. Journal of Immunology (1996), 157:5394-5402
30. Loke SL, Stein CA, Zhang XH, Mori K, Nakanishi M, Subasinghe C, Cohen JS, Neckers LM: Characterization of oligonucleotide transport into living cells. Proceeding of the National Academy of Science USA (1989), 86:3474-3478
31. Bennett RM: As nature intended? The uptake of DNA and oligonucleotides by eukaryotic cells. Antisense Research and Development (1993), 3:235-241
32. Tonkinson JL, Stein CA: Patterns of intracellular compartmentalization, trafficking and acidification of 5′-fluorescein labeled phosphodiester and phosphorothioate oligodeoxynucleotides in HL60 cells. Nucleic Acids Research (1994), 22:4268-4275
33. Stacey KJ, Sweet MJ, Hume DA: Macrophages ingest and are activated by bacterial DNA. Journal of Immunology (1996), 157:2116-2122
34. Sparwasser T, Miethke T, Lipford GB, Erdmann A, Häcker H, Heeg K, Wagner H: Macrophages sense pathogens via DNA motifs: Induction of TNF-alpha mediated shock. European Journal of Immunology (1997), 27:1671-1679
35. Sparwasser T, Miethke T, Lipford GH, Borschert K, Häcker H, Heeg K, Wagner H: Bacterial DNA cause septic shock. Nature (1997), 386:336-337
36. Lipford GB, Sparwasser T, Bauer M, Zimmermann S, Koch ES, Heeg K, Wagner H: Immunostimulatory DNA: sequence dependent production of potentially harmful or useful cytokines. European Journal of Immunology (1997), 27:3420-3426
37. Pisetsky DS: Immunostimulatory DNA: a clear and present danger? Nature Medicine (1997), 3:829-831
38. Heeg K, Lipford GB, Zimmermann S, Miethke T, Sparwasser T, Wagner H: Immunstimulierende Wirkung von bakterieller DNA und CpG-Oligonukleotiden: letales Zytokinsyndrom, Adjuvanseffekt und Induktion kurativer Th1-Antworten. Hygiene und Mikrobiologie (1997), 1:18-20
39. Rietschel ET, Brade H, Holst O, Brade L, Müller-Loennies S, Mamat U, Zähringer U, Beckmann F, Seydel U, Brandenburg K, Ulmer AJ, Mattern T, Heine H, Schletter J, Loppnow H, Schönbeck U, Flad H-D, Hauschildt S, Schade UF, di Padova F, Kusumoto S, Schumann RR: Bacterial endotoxin: chemical constitution, biological recognition, host response, and immunolouical detoxification. Current Topics in Microbiology and Immunology (1996), 216:39-81
40. Cowdery JS, Chace JH, Yi AK, Krieg AM: Bacterial DNA induces NK cells to produce IFN-gamma in vivo and increases the toxicity of lipopolysaccharides. Journal of Immunology (1996), 156:4570-4575
41. Chace JH, Hooker NA, Mildenstein KL, Krieg AM, Cowdery JS: Bacterial DNA-induced NK cell IFN-gamma production is dependent on macrophage secretion of IL-12. Clinical Immunology (1997), 84:185-193
42. Ozmen L, Pericin M, Hakimi J, Chizzonite RA, Wysocka M, Trinchieri G, Gately M, Garotta G: Interleukin 12, interferon gamma and tumor necrosis factor alpha are the key mediators of the generalized Shwartzman reaction. Journal of Experimental Medicine (1994), 180:907-915
43. Schwartz DA, Quinn TJ, Thorne PS, Sayeed S, Yi AK, Krieg AM: CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract. Journal of Clinical Investigations (1997), 100:1-6
44. Gregoriadis G: Immunological adjuvants: a role for liposomes. Immunology Today (1990), 11:89-97
45. Vogel FR, Powell MF: A compendium of vaccine adjuvants and excipients. In: Powell MF, Newman MJ (eds): Vaccine design. The subunit and adjuvant approach. Plenum Press, New York, 1995, p. 141-228
46. Lipford GB, Bauer M, Blank C, Reiter R, Wagner H, Heeg K: CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants. European Journal of Immunology (1997), 27:2340-2344
47. Chu RS, Targoni OS, Krieg AM, Lehmann PV, Harding CV: CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. Journal of Experimental Medicine (1997), 186:1623-1631
48. Weiner GJ, Liu HM, Wooldridge JE, Dahle CE, Krieg AM: Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization. Proceedings of the National Academy of Science USA (1997), 94:10833-10837
49. Klinman DM, Yamshchikov G, Ishigatsubo Y: Contribution of CpG motifs to the immunogenicity of DNA vaccines. Journal of Immunology (1997), 158:3635-3639
50. Sato Y, Roman M, Tighe H, Lee D, Corr M, Nguyen MD, Silverman GJ, Lotz M, Carson DA, Raz E: Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science (1996), 273:352-354
51. Mosmann TR, Sad S: The expanding universe of T cell subsets: Th1, Th2 and more. Immunology Today (1996), 17:138-146
52. Roman M, Martin-Orozco E, Goodman JS, Nguyen M-D, Sato Y, Ronaghy A, Kornbluth RS, Richman DD, Carson DA, Raz E: Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nature Medicine (1997), 3:849-854
53. Zimmermann S, Egeter O, Hausmann S, Lipford GB, Röcken M, Wagner H, Heeg K: CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis. Journal of Immunology (1998), 160:3627-3630
54. Shirakawa T, Enomoto T, Shimazu SI, Hopkin JM: The inverse association between tuberculin responses and atopic disorder. Science (1997), 275:77-79